Interventional Nephrology, ULS São João
#POCUS #VascularAccess #CardioRenal
Finerenone + Empagliflozin 52% drop in UACR at 180 days;
More patients achieve the therapeutic targets
Combination with less HiperK+! #ERA25
Finerenone + Empagliflozin 52% drop in UACR at 180 days;
More patients achieve the therapeutic targets
Combination with less HiperK+! #ERA25